Atrasentan HCl
Catalog No. A15007
Atrasentan hydrochloride是一种开发用于治疗前列腺癌的内皮素拮抗剂受体(IC50 = 0.0551 nM,ETA)。
Catalog Num | A15007 |
---|---|
M. Wt | 547.08 |
Formula | C29H39ClN2O6 |
Purity | >98% |
Storage | at -20°C 3 years Powder |
CAS No. | 195733-43-8 |
Synonyms | ABT-627, ABT627, ABT 627 |
SMILES | CCCCN(CCCC)C(=O)CN1CC(C(C1C2=CC=C(C=C2)OC)C(=O)O)C3=CC4=C(C=C3)OCO4.Cl |
Atrasentan hydrochloride是一种开发用于治疗前列腺癌的内皮素拮抗剂受体(IC50 = 0.0551 nM,ETA)。
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 18.28 mL | 91.39 mL | 182.79 mL |
0.5 mM | 3.66 mL | 18.28 mL | 36.56 mL |
1 mM | 1.83 mL | 9.14 mL | 18.28 mL |
5 mM | 0.37 mL | 1.83 mL | 3.66 mL |
*The above data is based on the productmolecular weight 547.08. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.